Skip to Main Content

Author Details

Vaibhav Chumbalkar
Moffitt Cancer Center
2005
18
9
PMIDPaper TitleJournal TitlePublished Year
37434893An insight into metastatic Leydig cell tumors: A case report.SAGE Open Med Case Rep2023
34815169Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series.Urol Oncol2022
35275846Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma.Adv Anat Pathol2022
34929230Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration.Hum Pathol2022
33783025Seminal vesicle cystadenoma with dysplasia: missing link to adenocarcinoma?Histopathology2021
33625095A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.J Pediatr Hematol Oncol2021
30737763Gastric Lipohyperplasia Presenting as Gastric Polyposis: the First Case Report and Morphometric Study of Additional 127 Bariatric Specimens with a Proposal for Diagnostic Criteria.Obes Surg2019
29905844Robotic Assisted MRI-Guided Interventional Interstitial MR-Guided Focused Ultrasound Ablation in a Swine Model.Neurosurgery2019
28597108Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.Hepatol Int2017
28058078Extramammary Paget's Disease of Anal Canal Associated With Rectal Adenoma Without Invasive Carcinoma.Gastroenterology Res2016
22729867Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.Int J Cancer2013
23359207Regulation of HGF expression by οEGFR-mediated c-Met activation in glioblastoma cells.Neoplasia2013
20473884Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.Int J Cancer2011
21775422Forced dimerization increases the activity of οEGFR/EGFRvIII and enhances its oncogenicity.Mol Cancer Res2011
21214269Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of οEGFR.J Proteome Res2011
20713409The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.Neuro Oncol2010
18501776Proteomics: the new frontier also for brain tumor research.Curr Probl Cancer2008
15759318Differential protein expression in human gliomas and molecular insights.Proteomics2005
  • 1 - 18 of 18

Recommended Authors

Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 0
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 1
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 0
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 2
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 1
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 0
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 1997
Number of shared co-authors 0
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 3
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 1
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 2
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 0
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 1
Queen's University
Career Start Year 1982
Number of shared co-authors 0
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 2
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 7
Baylor College of Medicine
Co-authored papers 5
University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
National Cancer Center
Co-authored papers 2
Virginia Commonwealth University, United States of America Massey Cancer Center
Co-authored papers 2
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 2
National Institute of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers 2
University of California San Diego
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
University Hospital Zurich
Co-authored papers 1
University of Texas Medical Branch
Co-authored papers 1
Markey Cancer Center, University of Kentucky
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Haida Hospital
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
PHusis Therapeutics Inc.
Co-authored papers 1
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Mahidol University
Co-authored papers 1
Dell Medical School, University of Texas at Austin
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Fukuoka University
Co-authored papers 1
LAC+USC Medical Center, University of Southern California
Co-authored papers 1